Bausch Health Companies (TSE:BHC) Stock Price Down 1.4% – Time to Sell?

Bausch Health Companies Inc. (TSE:BHC) was down 1.4% during trading on Monday . The company traded as low as C$7.70 and last traded at C$8.01. Approximately 746,307 shares were traded during mid-day trading, an increase of 109% from the average daily volume of 356,868 shares. The stock had previously closed at C$8.12.

Bausch Health Companies Price Performance

The firm has a market capitalization of C$2.08 billion, a P/E ratio of -11.72, a P/E/G ratio of 0.21 and a beta of 0.77. The business’s fifty day moving average is C$6.74 and its 200 day moving average is C$9.08. The company has a current ratio of 1.19, a quick ratio of 0.58 and a debt-to-equity ratio of -1,831.94.

Insiders Place Their Bets

In related news, Director John Paulson purchased 502,688 shares of the firm’s stock in a transaction that occurred on Thursday, June 12th. The stock was acquired at an average price of C$7.44 per share, for a total transaction of C$3,739,596.57. Over the last 90 days, insiders have acquired 1,771,371 shares of company stock worth $12,585,871. 11.28% of the stock is owned by insiders.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.